These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 30935403)

  • 1. Mild thermotherapy and hyperbaric oxygen enhance sensitivity of TMZ/PSi nanoparticles via decreasing the stemness in glioma.
    Zeng X; Wang Q; Tan X; Jia L; Li Y; Hu M; Zhang Z; Bai X; Zhu Y; Yang X
    J Nanobiotechnology; 2019 Apr; 17(1):47. PubMed ID: 30935403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperbaric oxygen as an adjuvant to temozolomide nanoparticle inhibits glioma growth by inducing G2/M phase arrest.
    Xie Y; Zeng X; Wu X; Hu J; Zhu Y; Yang X
    Nanomedicine (Lond); 2018 Apr; 13(8):887-898. PubMed ID: 29473458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The synergistic therapeutic effect of temozolomide and hyperbaric oxygen on glioma U251 cell lines is accompanied by alterations in vascular endothelial growth factor and multidrug resistance-associated protein-1 levels.
    Lu XY; Cao K; Li QY; Yuan ZC; Lu PS
    J Int Med Res; 2012; 40(3):995-1004. PubMed ID: 22906272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination hyperbaric oxygen and temozolomide therapy in C6 rat glioma model.
    Dagıstan Y; Karaca I; Bozkurt ER; Ozar E; Yagmurlu K; Toklu A; Bilir A
    Acta Cir Bras; 2012 Jun; 27(6):383-7. PubMed ID: 22666755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of transferrin-modified poly(lactic-co-glycolic acid) nanoparticles for glioma therapy.
    Mao J; Meng X; Zhao C; Yang Y; Liu G
    Anticancer Drugs; 2019 Jul; 30(6):604-610. PubMed ID: 30855310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic Suppression of Glioblastoma Cell Growth by Combined Application of Temozolomide and Dopamine D2 Receptor Antagonists.
    Liu Z; Jiang X; Gao L; Liu X; Li J; Huang X; Zeng T
    World Neurosurg; 2019 Aug; 128():e468-e477. PubMed ID: 31048057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of transferrin-targeted temozolomide nano-micelles and their anti-glioma effect.
    Yu J; Xue Y
    PeerJ; 2024; 12():e17979. PubMed ID: 39285923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergy of enediyne antibiotic lidamycin and temozolomide in suppressing glioma growth with potentiated apoptosis induction.
    Li XQ; Ouyang ZG; Zhang SH; Liu H; Shang Y; Li Y; Zhen YS
    J Neurooncol; 2014 Aug; 119(1):91-100. PubMed ID: 24842385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of surface-modified porous silicon nanoparticles to deliver temozolomide with enhanced pharmacokinetic and therapeutic efficacy for intracranial glioblastoma in mice.
    Shin S; Jo H; Agura T; Jeong S; Ahn H; Kim Y; Kang JS
    J Mater Chem B; 2024 Sep; 12(37):9335-9344. PubMed ID: 39171683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Far-infrared Ray on Temozolomide-treated Glioma in Rats.
    Chen JC; Hwang JH
    In Vivo; 2019; 33(4):1203-1208. PubMed ID: 31280210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
    Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
    Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fabrication of pH-responsive temozolomide (TMZ)-clacked tannic acid-altered zeolite imidazole nanoframeworks (ZIF-8) enhance anticancer activity and apoptosis induction in glioma cancer cells.
    Ren C; Tu Q; He J
    J Biomater Sci Polym Ed; 2024 Sep; 35(13):1978-1998. PubMed ID: 38953298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temozolomide loaded PLGA-based superparamagnetic nanoparticles for magnetic resonance imaging and treatment of malignant glioma.
    Ling Y; Wei K; Zou F; Zhong S
    Int J Pharm; 2012 Jul; 430(1-2):266-75. PubMed ID: 22486964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquisition of temozolomide resistance by the rat C6 glioma cell line increases cell migration and side population phenotype.
    Xu Y; Yang X; Mei S; Sun Y; Li J
    Oncol Rep; 2019 Dec; 42(6):2355-2362. PubMed ID: 31578583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoplatelets modified with RVG for targeted delivery of miR-375 and temozolomide to enhance gliomas therapy.
    Yang T; Zhang N; Liu Y; Yang R; Wei Z; Liu F; Song D; Wang L; Wei J; Li Y; Shen D; Liang G
    J Nanobiotechnology; 2024 Oct; 22(1):623. PubMed ID: 39402578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DMC is not better than TMZ on intracranial anti-glioma effects.
    Shi L; Sun G
    J Cell Biochem; 2018 Jul; 119(7):6057-6064. PubMed ID: 29575236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway.
    Bi Y; Li H; Yi D; Sun Y; Bai Y; Zhong S; Song Y; Zhao G; Chen Y
    Mol Pharm; 2018 Nov; 15(11):4912-4925. PubMed ID: 30336060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temozolomide inhibits cellular growth and motility via targeting ERK signaling in glioma C6 cells.
    Wang Y; Gao S; Wang W; Liang J
    Mol Med Rep; 2016 Dec; 14(6):5732-5738. PubMed ID: 27878252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical evaluation of binimetinib (MEK162) delivered via polymeric nanocarriers in combination with radiation and temozolomide in glioma.
    Bikhezar F; de Kruijff RM; van der Meer AJGM; Torrelo Villa G; van der Pol SMA; Becerril Aragon G; Gasol Garcia A; Narayan RS; de Vries HE; Slotman BJ; Denkova AG; Sminia P
    J Neurooncol; 2020 Jan; 146(2):239-246. PubMed ID: 31875307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic Anticancer Effects of Formononetin and Temozolomide on Glioma C6 Cells.
    Zhang X; Ni Q; Wang Y; Fan H; Li Y
    Biol Pharm Bull; 2018 Aug; 41(8):1194-1202. PubMed ID: 29848900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.